It’s the battle of the MYMP! Drs. Caza, Cassol, and Larsen have recently published papers discussing CXCR5 + CD8 + T cellular therapy, cubilin & amnionless protein, EXT1 & NCAM1-associated membranous lupus nephritis, & lupus nephritis. Read each paper below!
Cubilin and amnionless protein are novel target antigens in anti–brush border antibody disease
Quick note: This post is to be used for informational purposes only and does not constitute medical or health advice. Each person should consult their own doctor with respect to matters referenced. Arkana Laboratories assumes no liability for actions taken in reliance upon the information contained herein.
